Literature DB >> 8855867

Low-efficacy HIV vaccines: potential for community-based intervention programmes.

R M Anderson1, G P Garnett.   

Abstract

To combat the spread of HIV, progress on vaccine development is eagerly awaited. Haynes in this series has described the progress made so far with various vaccine types. This article describes how mathematical modelling techniques can be used to predict the likely impact of low-efficacy vaccines in community transmission of the virus. The answers are often not what one would predict by intuition alone, and they have great bearing on the likely success of such vaccination strategies.

Mesh:

Substances:

Year:  1996        PMID: 8855867     DOI: 10.1016/s0140-6736(96)07100-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

Review 1.  Microbicides in HIV prevention.

Authors:  S McCormack; R Hayes; C J Lacey; A M Johnson
Journal:  BMJ       Date:  2001-02-17

Review 2.  An introduction to mathematical models in sexually transmitted disease epidemiology.

Authors:  G P Garnett
Journal:  Sex Transm Infect       Date:  2002-02       Impact factor: 3.519

3.  HIV vaccine knowledge and beliefs among communities at elevated risk: conspiracies, questions and confusion.

Authors:  Kathleen Johnston Roberts; Peter A Newman; Naihua Duan; Ellen T Rudy
Journal:  J Natl Med Assoc       Date:  2005-12       Impact factor: 1.798

4.  Preparing for the availability of a partially effective HIV vaccine: some lessons from other licensed vaccines.

Authors:  Robert T Chen; Dale J Hu; Eileen Dunne; Michael Shaw; James I Mullins; Supachai Rerks-Ngarm
Journal:  Vaccine       Date:  2011-07-13       Impact factor: 3.641

5.  HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics.

Authors:  Peter A Newman; Naihua Duan; Sung-Jae Lee; Ellen T Rudy; Danielle S Seiden; Lisa Kakinami; William E Cunningham
Journal:  Vaccine       Date:  2005-11-21       Impact factor: 3.641

6.  Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination.

Authors:  M Kibur; V af Geijerstamm; E Pukkala; P Koskela; T Luostarinen; J Paavonen; J Schiller; Z Wang; J Dillner; M Lehtinen
Journal:  Sex Transm Infect       Date:  2000-02       Impact factor: 3.519

7.  Predicting the impact of a nonsterilizing vaccine against human immunodeficiency virus.

Authors:  Miles P Davenport; Ruy M Ribeiro; Dennis L Chao; Alan S Perelson
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example.

Authors:  Kyeen M Andersson; Douglas K Owens; Eftyhia Vardas; Glenda E Gray; James A McIntyre; A David Paltiel
Journal:  J Acquir Immune Defic Syndr       Date:  2007-09-01       Impact factor: 3.731

9.  Spillover effects in epidemiology: parameters, study designs and methodological considerations.

Authors:  Jade Benjamin-Chung; Benjamin F Arnold; David Berger; Stephen P Luby; Edward Miguel; John M Colford; Alan E Hubbard
Journal:  Int J Epidemiol       Date:  2018-02-01       Impact factor: 7.196

10.  Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development.

Authors:  Yoshiaki Nishimura; Tatsuhiko Igarashi; Nancy L Haigwood; Reza Sadjadpour; Olivia K Donau; Charles Buckler; Ron J Plishka; Alicia Buckler-White; Malcolm A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.